Total Payments
$95,538
2023 Payments
$2,600
Companies
10
Transactions
75
Payment Breakdown by Category
Consulting$74,440 (77.9%)
Travel$10,511 (11.0%)
Research$6,237 (6.5%)
Other$2,893 (3.0%)
Food & Beverage$1,456 (1.5%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $74,440 | 24 | 77.9% |
| Travel and Lodging | $10,511 | 23 | 11.0% |
| Unspecified | $6,237 | 3 | 6.5% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $2,857 | 5 | 3.0% |
| Food and Beverage | $1,456 | 19 | 1.5% |
| Compensation for serving as faculty or as a speaker for a non-accredited and noncertified continuing education program | $36.53 | 1 | 0.0% |
Payments by Type
General
$89,301
72 transactions
Research
$6,237
3 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Amgen Inc. | $44,416 | 25 | $0 (2022) |
| JAZZ PHARMACEUTICALS INC. | $18,615 | 15 | $0 (2021) |
| Novartis Pharmaceuticals Corporation | $17,047 | 19 | $0 (2021) |
| Shire North American Group Inc | $4,800 | 1 | $0 (2017) |
| Servier Pharmaceuticals LLC | $3,759 | 7 | $0 (2019) |
| Takeda Pharmaceuticals U.S.A., Inc. | $2,640 | 1 | $0 (2020) |
| BeiGene, Ltd. | $2,600 | 1 | $0 (2023) |
| Celgene Corporation | $1,536 | 3 | $0 (2018) |
| AstraZeneca Pharmaceuticals LP | $88.15 | 2 | $0 (2021) |
| E.R. Squibb & Sons, L.L.C. | $36.53 | 1 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $2,600 | 1 | BeiGene, Ltd. ($2,600) |
| 2022 | $8,140 | 3 | Amgen Inc. ($8,140) |
| 2021 | $19,678 | 8 | Novartis Pharmaceuticals Corporation ($10,614) |
| 2020 | $6,985 | 4 | Amgen Inc. ($4,345) |
| 2019 | $17,609 | 23 | Amgen Inc. ($12,123) |
| 2018 | $20,685 | 22 | Jazz Pharmaceuticals Inc. ($11,685) |
| 2017 | $19,840 | 14 | Amgen Inc. ($14,406) |
All Payment Transactions
75 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 02/22/2023 | BeiGene, Ltd. | BRUKINSA (Drug) | Consulting Fee | Cash or cash equivalent | $2,600.00 | General |
| Category: Oncology | ||||||
| 02/25/2022 | Amgen Inc. | Blincyto (Biological) | Consulting Fee | Cash or cash equivalent | $3,894.00 | General |
| Category: Oncology | ||||||
| 02/23/2022 | Amgen Inc. | Blincyto (Biological) | Consulting Fee | Cash or cash equivalent | $2,596.00 | General |
| Category: Oncology | ||||||
| 01/24/2022 | Amgen Inc. | Blincyto (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,650.00 | General |
| Category: Oncology | ||||||
| 12/10/2021 | Novartis Pharmaceuticals Corporation | KYMRIAH (Biological) | Consulting Fee | Cash or cash equivalent | $4,392.00 | General |
| Category: ONCOLOGY | ||||||
| 11/19/2021 | JAZZ PHARMACEUTICALS INC. | RYLAZE (Drug) | Consulting Fee | Cash or cash equivalent | $3,180.00 | General |
| Category: HEMATOLOGY/ONCOLOGY | ||||||
| 11/16/2021 | Novartis Pharmaceuticals Corporation | KYMRIAH (Biological) | Consulting Fee | Cash or cash equivalent | $3,294.00 | General |
| Category: ONCOLOGY | ||||||
| 10/19/2021 | AstraZeneca Pharmaceuticals LP | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $66.67 | General |
| 10/19/2021 | AstraZeneca Pharmaceuticals LP | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $21.48 | General |
| 10/06/2021 | Amgen Inc. | Blincyto (Biological) | Consulting Fee | Cash or cash equivalent | $2,596.00 | General |
| Category: Oncology | ||||||
| 05/24/2021 | JAZZ PHARMACEUTICALS INC. | RYLAZE (Drug) | Consulting Fee | Cash or cash equivalent | $3,200.00 | General |
| Category: HEMATOLOGY/ONCOLOGY | ||||||
| 03/24/2021 | Novartis Pharmaceuticals Corporation | KYMRIAH (Biological) | Consulting Fee | Cash or cash equivalent | $2,928.00 | General |
| Category: ONCOLOGY | ||||||
| 12/16/2020 | Amgen Inc. | Blincyto (Biological) | Consulting Fee | Cash or cash equivalent | $1,100.00 | General |
| Category: Oncology | ||||||
| 12/04/2020 | Amgen Inc. | Blincyto (Biological) | Consulting Fee | Cash or cash equivalent | $2,596.00 | General |
| Category: Oncology | ||||||
| 12/04/2020 | Amgen Inc. | Blincyto (Biological) | Consulting Fee | Cash or cash equivalent | $649.00 | General |
| Category: Oncology | ||||||
| 10/22/2020 | Takeda Pharmaceuticals U.S.A., Inc. | — | Consulting Fee | Cash or cash equivalent | $2,640.00 | General |
| 12/10/2019 | Amgen Inc. | — | Travel and Lodging | In-kind items and services | $14.39 | General |
| 12/06/2019 | NOVARTIS PHARMACEUTICALS CORPORATION | — | Food and Beverage | In-kind items and services | $125.00 | General |
| 11/20/2019 | Amgen Inc. | Blincyto (Biological) | Consulting Fee | Cash or cash equivalent | $4,400.00 | General |
| Category: Oncology | ||||||
| 11/20/2019 | Amgen Inc. | Blincyto (Biological) | Consulting Fee | Cash or cash equivalent | $3,850.00 | General |
| Category: Oncology | ||||||
| 10/18/2019 | Novartis Pharmaceuticals Corporation | KYMRIAH (Biological) | Food and Beverage | In-kind items and services | $134.98 | General |
| Category: ONCOLOGY | ||||||
| 10/17/2019 | Novartis Pharmaceuticals Corporation | — | Travel and Lodging | In-kind items and services | $409.00 | General |
| 10/17/2019 | Novartis Pharmaceuticals Corporation | KYMRIAH (Biological) | Travel and Lodging | In-kind items and services | $207.47 | General |
| Category: ONCOLOGY | ||||||
| 10/17/2019 | Novartis Pharmaceuticals Corporation | KYMRIAH (Biological) | Food and Beverage | In-kind items and services | $124.99 | General |
| Category: ONCOLOGY | ||||||
| 10/17/2019 | Novartis Pharmaceuticals Corporation | KYMRIAH (Biological) | Food and Beverage | In-kind items and services | $74.99 | General |
| Category: ONCOLOGY | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| Ph1b2 ALL Pediatric | Amgen Inc. | $5,820 | 2 |
| CC-5013-AML-002 | Celgene Corporation | $417.00 | 1 |
About Dr. Patrick Brown, M.D
Dr. Patrick Brown, M.D is a Medical Oncology healthcare provider based in Baltimore, Maryland. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/03/2006. The National Provider Identifier (NPI) number assigned to this provider is 1154389633.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Patrick Brown, M.D has received a total of $95,538 in payments from pharmaceutical and medical device companies, with $2,600 received in 2023. These payments were reported across 75 transactions from 10 companies. The most common payment nature is "Consulting Fee" ($74,440).
Ad
Practice Information
- Specialty Medical Oncology
- Location Baltimore, MD
- Active Since 05/03/2006
- Last Updated 01/10/2014
- Taxonomy Code 207RX0202X
- Entity Type Individual
- NPI Number 1154389633
Products in Payments
- Blincyto (Biological) $41,543
- KYMRIAH (Biological) $11,504
- Erwinaze (Drug) $10,302
- RYLAZE (Drug) $6,380
- ONCASPAR (Biological) $4,800
- ONCASPAR (Drug) $3,759
- BRUKINSA (Drug) $2,600
- Kyprolis (Biological) $2,200
- Revlimid (Drug) $1,499
- ERWINAZE (Drug) $550.00
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Medical Oncology Doctors in Baltimore
Mario Eisenberger, M.d, M.D
Medical Oncology — Payments: $2.9M
Medical Oncology $2.9M
Dr. Tanguy Seiwert, M.d, M.D
Medical Oncology — Payments: $622,422
Medical Oncology $622,422
Carole Miller, Md, MD
Medical Oncology — Payments: $587,841
Medical Oncology $587,841
Bruce Smith, M.d, M.D
Medical Oncology — Payments: $406,689
Medical Oncology $406,689
Carol Huff, M.d, M.D
Medical Oncology — Payments: $384,580
Medical Oncology $384,580
Leisha Emens
Medical Oncology — Payments: $252,501
Medical Oncology $252,501